|
|
||||||||
Letters to the Editor |
1 University Womens Hospital, University of Basel, Basel, Switzerland
2 Division of Paediatric Nephrology, University of the Witwatersrand, and Johannesburg Hospital, Johannesburg, South Africa
aAddress correspondence to this author at: Laboratory for Prenatal Medicine, University Womens Hospital/Department of Research, Spitalstrasse 21, CH 4031 Basel, Switzerland. Fax 41-61-265-9399; e-mail shahn@unbs.ch.
| The first 20% of the full text of this article appears below. |
To the Editor:
Several studies have reported that transplant-derived cell-free DNA (CF-DNA) can be detected in the urine of renal transplant recipients (1)(2)(3)(4)(5). These studies have indicated that the increased excretion of CF-DNA is associated with acute graft rejection but not with drug-induced kidney dysfunction (1)(2)(3)(5).
A limitation of these studies was that they frequently relied on the detection of Y-chromosomespecific sequences in sex-disparate donorrecipient pairs (1)(2)(5). Although the use of specific human lymphocyte antigens mismatches was examined, this approach is reliably useful only when donor and recipient are unrelated (5). We previously reported that the analysis
The following articles in journals at HighWire Press have cited this article:
![]() |
Y. Li, W. Holzgreve, V. Kiefer, and S. Hahn MALDI-TOF Mass Spectrometry Compared With Real-Time PCR for Detection of Fetal Cell-Free DNA in Maternal Plasma Clin. Chem., December 1, 2006; 52(12): 2311 - 2312. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |